Inari Medical, Inc. (NARI)
NASDAQ: NARI · Real-Time Price · USD
50.97
-0.35 (-0.68%)
Nov 19, 2024, 4:00 PM EST - Market closed
Inari Medical Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$59.13
Upside
+16.01%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 30, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $46 → $50 | Hold | Maintains | $46 → $50 | -1.90% | Oct 29, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $50 → $52 | Hold | Maintains | $50 → $52 | +2.02% | Oct 29, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $71 → $74 | Strong Buy | Maintains | $71 → $74 | +45.18% | Oct 29, 2024 |
| Baird | Baird | Buy Maintains $66 → $67 | Buy | Maintains | $66 → $67 | +31.45% | Oct 29, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 29, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $55 → $46 | Hold | Maintains | $55 → $46 | -9.75% | Oct 14, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 9, 2024 |
| Stifel | Stifel | Hold Initiates $50 | Hold | Initiates | $50 | -1.90% | Sep 17, 2024 |
| Leerink Partners | Leerink Partners | Hold Initiates $47 | Hold | Initiates | $47 | -7.79% | Sep 3, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $50 | Hold | Maintains | $50 | -1.90% | Aug 26, 2024 |
| Deutsche Bank | Deutsche Bank | Strong Buy Initiates $68 | Strong Buy | Initiates | $68 | +33.41% | Aug 9, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $84 → $65 | Buy | Maintains | $84 → $65 | +27.53% | Jul 31, 2024 |
| Truist Securities | Truist Securities | Hold Reiterates $60 → $55 | Hold | Reiterates | $60 → $55 | +7.91% | Jul 31, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $55 → $71 | Strong Buy | Maintains | $55 → $71 | +39.30% | Jul 31, 2024 |
| Baird | Baird | Buy Maintains $65 → $63 | Buy | Maintains | $65 → $63 | +23.60% | Jul 31, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.